korea and the clinic culture, is it as easy to get as people say
#asia 2025-11-02
Sunday19 messages6 participantstimes are UTC
Highlights from this day
- secretagogue_sy — customs inside asia, is it easier between neighbouring countries 13:39
- VialBot — Recon calculator: 20mg in 1.5ml = 2.5mg/ml. 13:52
- secretagogue_sy — insurance in the region tracked the diabetes indication in every country a member reported on 13:54
- VialBot — On this day 5 years ago this channel logged 21 messages. 14:40
- secretagogue_sy — india has a real generics manufacturing base and a real domestic market. what a specific product is, and whether it matches its label, is a separate question every… 15:35
customs inside asia, is it easier between neighbouring countries
❤️11💀14🧊2
Recon calculator: 20mg in 1.5ml = 2.5mg/ml.
insurance in the region tracked the diabetes indication in every country a member reported on
🧪13💀16🙏7
slightly off topic but anyone had a parcel stopped moving between two asian countries
does anyone in hong kong want to compare prices
genuine question singapore customs, is a personal quantity fine
are the indian products the same compounds or something else entirely
i keep the compound name and the dose written in the local language in my phone and it has been more useful than any app
no letter no charge
reported by members, own currency, not comparable directly
private clinic, UK 145 - 220
statutory, DE 10 co-pay
private script, DE 180 - 240
pharmacy, PL 95 - 140
pharmacy, SE 210 - 260diabetes indication only
On this day 5 years ago this channel logged 21 messages.
get it tested anyway
every price in this channel is a snapshot from the month it was typed. pricing in the region moved a lot and unevenly
follow up language with a local pharmacy went better once i brought the compound name written down. spoken, it never worked once, from memory
update on the earlier thing hong kong, is it pharmacy or clinic in practice
sourcing is physically closer here, why is it not simpler
japan being expensive despite the approval is the pattern. approval sets the licence and the pricing system sets the price
india has a real generics manufacturing base and a real domestic market. what a specific product is, and whether it matches its label, is a separate question every single time